Comparative Proteome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteogenomics

Conclusion: Altered mutant peptides present in PCa tissue could be used as new biomarkers in advanced PCa.

Source: Cancer Genomics and Proteomics - June 25, 2019 Category: Cancer & Oncology Authors: KWON, O. K., HA, Y.-S., LEE, J. N., KIM, S., LEE, H., CHUN, S. Y., KWON, T. G., LEE, S. Tags: Article Source Type: research